Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
57 hedge funds and large institutions have $196M invested in Syneron Medical Ltd in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
9% more capital invested
Capital invested by funds: $180M → $196M (+$15.9M)
14% less funds holding
Funds holding: 66 → 57 (-9)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
89% less call options, than puts
Call options by funds: $2K | Put options by funds: $19K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$11.5M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$8.96M |
| 3 |
IAM
Ion Asset Management
Herzliya,
Israel
|
+$5.4M |
| 4 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$3.81M |
| 5 |
CAD
Craig A. Drill
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$14.9M |
| 2 |
HC
Hourglass Capital
Houston,
Texas
|
-$5.07M |
| 3 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$3.46M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.4M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.32M |
ELOS Hedge Fund Activity: Q4 2015 in Review
57 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2015, worth a combined $196M — up 8.8% from $180M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ELOS and 8 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 18 added.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $11.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $14.9M sold.
- 57 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2015, down from 66 in Q3 2015.
- Funds reported $196M of Syneron Medical Ltd stock for Q4 2015, up 8.8% quarter-over-quarter.
- 8 funds opened new Syneron Medical Ltd positions in Q4 2015 and 17 closed out, a net change of -9 holders.
- The largest Syneron Medical Ltd buyer in Q4 2015 was Camber Capital Management, an estimated $11.5M added.
- The largest Syneron Medical Ltd seller in Q4 2015 was Deerfield Management, an estimated $14.9M sold.
Based on aggregated 13F filings for Q4 2015.